Overview

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

Status:
NOT_YET_RECRUITING
Trial end date:
2026-12-30
Target enrollment:
Participant gender:
Summary
Evaluation the possible efficacy and safety of febuxostat in patients with ulcerative colitis treated with mesalamine.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Tanta University
Treatments:
Febuxostat
Mesalamine